Chemmedchem 2008-11-01

Synthesis and properties of a mitochondrial peripheral benzodiazepine receptor conjugate.

Abdessamad El Alaoui, Frédéric Schmidt, Marianne Sarr, Didier Decaudin, Jean-Claude Florent, Ludger Johannes

Index: ChemMedChem 3(11) , 1687-95, (2008)

Full Text: HTML

Abstract

Peripheral benzodiazepine receptors are potential targets for cancer therapeutics through the use of specific ligands such as the pro-apoptotic benzodiazepine RO5-4864. However, the poor water solubility of this compound has been a limitation to its application in vivo. Herein we describe an efficient synthesis for the conjugation, via a cleavable linker arm, of RO5-4864 to a novel tumour-delivery tool, the B-subunit of Shiga toxin (STxB). The conjugate is water soluble and specifically targets cancer cells that overexpress the glycolipid Gb3, the cellular Shiga toxin receptor that is found on several human tumours. After internalisation via retrograde transport, the prodrug is cleaved inside cells to release the active principle. Delivery by STxB therefore increases the cytotoxic activity of RO5-4864 and its tumour specificity.


Related Compounds

Related Articles:

LC–MS/MS analysis of plasma lyso-Gb3 in Fabry disease

2012-12-24

[Clin. Chim. Acta 414 , 273-80, (2012)]

A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers.

2013-01-01

[Curr. Med. Chem. 20(2) , 280-8, (2013)]

In vivo tumor targeting using a novel intestinal pathogen-based delivery approach.

2006-07-15

[Cancer Res. 66(14) , 7230-6, (2006)]

Plasma globotriaosylsphingosine as a biomarker of Fabry disease.

2010-07-01

[Mol. Genet. Metab. 100(3) , 257-61, (2010)]

Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometry.

2012-02-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 883-884 , 128-35, (2012)]

More Articles...